Patents by Inventor Matthew Miles Magee

Matthew Miles Magee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10092363
    Abstract: A system includes a microprocessor executable verification module in a base unit and a microprocessor readable identifier of an endovasoular device in a memory of the endovascular device. The microprocessor executable verification module, based on the identifier, at least one of configures the endovascular device for use and determines whether the endovascular device can be enabled for use.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: October 9, 2018
    Assignee: The Spectranetics Corporation
    Inventors: Matthew Miles Magee, Paul Andrew Hollendorfer
  • Publication number: 20170348058
    Abstract: A system includes a microprocessor executable verification module in a base unit and a microprocessor readable identifier of an endovasoular device in a memory of the endovascular device. The microprocessor executable verification module, based on the identifier, at least one of configures the endovascular device for use and determines whether the endovascular device can be enabled for use.
    Type: Application
    Filed: July 10, 2017
    Publication date: December 7, 2017
    Inventors: Matthew Miles Magee, Paul Andrew Hollendorfer
  • Patent number: 9757200
    Abstract: A system includes a microprocessor executable verification module in a base unit and a microprocessor readable identifier of an endovascular device in a memory of the endovascular device. The microprocessor executable verification module, based on the identifier, at least one of configures the endovascular device for use and determines whether the endovascular device can be enabled for use.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 12, 2017
    Assignee: The Spectranetics Corporation
    Inventors: Matthew Miles Magee, Paul Andrew Hollendorfer
  • Patent number: 9358042
    Abstract: Lead extraction is the removal of one or more leads from inside the heart utilizing a lead removal catheter having a tubular sheath that is placed in the blood vessel, either subclavian or femoral. The sheath of the lead removal catheter may accidentally tear or perforate the blood vessel as it is advanced over the lead toward the heart. Such an occurrence must be dealt with quickly to prevent harm to the patient or subject. An expandable member, such as a balloon, attached to the exterior of the sheath of a lead removal catheter can be deployed temporarily adjacent the perforation in the vessel wall. Inflation of the balloon not only stops (or substantially stops) the bleeding, but, upon inflation, the balloon may include one or more channels that allow blood to continue to flow through the channel(s) until the blood vessel perforation can be repaired.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 7, 2016
    Assignee: The Spectranetics Corporation
    Inventor: Matthew Miles Magee
  • Publication number: 20140276402
    Abstract: Lead extraction is the removal of one or more leads from inside the heart utilizing a lead removal catheter having a tubular sheath that is placed in the blood vessel, either subclavian or femoral. The sheath of the lead removal catheter may accidentally tear or perforate the blood vesselas it is advanced over the lead toward the heart. Such an occurrence must be dealt with quickly to prevent harm to the patient or subject. An expandable member, such as a balloon, attached to the exterior of the sheath of a lead removal catheter can be deployed temporarily adjacent the perforation in the vessel wall. Inflation of the balloon not only stops (or substantially stops) the bleeding, but, upon inflation, the balloon may include one or more channels that allow blood to continue to flow through the channel(s) until the blood vessel perforation can be repaired.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 18, 2014
    Applicant: The Spectranetics Corporation
    Inventor: Matthew Miles Magee
  • Publication number: 20140276603
    Abstract: A system includes a microprocessor executable verification module in a base unit and a microprocessor readable identifier of an endovascular device in a memory of the endovascular device. The microprocessor executable verification module, based on the identifier, at least one of configures the endovascular device for use and determines whether the endovascular device can be enabled for use.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: The Spectranetics Corporation
    Inventors: Matthew Miles Magee, Paul Andrew Hollendorfer
  • Patent number: D775728
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: January 3, 2017
    Assignee: The Spectranetics Corporation
    Inventors: Gilberto Cavada, Martin J. Kimbell, Matthew Errol Zotter, Matthew Miles Magee, Steven Thomas Saville, Timothy J. Hale, Jeffery David Payne, Deepa Deepa